$225 Million Stock Purchase in Health Care Industry
The attorneys at Kegler Brown advised a publicly traded, global medical technology company in connection with its May 2010 stock purchase bid for a leading innovator in clinically differentiated needleless access connectors and administration sets that deliver intravenous medication to patients.